-
171.
公开(公告)号:US20210002673A1
公开(公告)日:2021-01-07
申请号:US16888339
申请日:2020-05-29
Applicant: Genomatica, Inc.
Inventor: Stephanie J. Culler , Mark J. Burk , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides a non-naturally occurring microbial organism having a butadiene, crotyl alcohol, 2,4-pentadienoate, 3-buten-2-ol, or 3-buten-1-ol, pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in a pathway. The invention additionally provides a method for producing butadiene, crotyl alcohol, 2,4-pentadienoate, 3-buten-2-ol, or 3-buten-1-ol. The method can include culturing a butadiene, crotyl alcohol, 2,4-pentadienoate, 3-buten-2-ol, or 3-buten-1-ol-producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a pathway enzyme in a sufficient amount, and under conditions and for a sufficient period of time to produce butadiene, crotyl alcohol, 2,4-pentadienoate, 3-buten-2-ol, or 3-buten-1-ol.
-
公开(公告)号:US20200370024A1
公开(公告)日:2020-11-26
申请号:US16661667
申请日:2019-10-23
Applicant: Genomatica, Inc.
Inventor: Baolong ZHU , Andreas W. Schirmer , Cindy CHANG
Abstract: The disclosure relates to omega-hydroxylase-related fusion polypeptides that result in improved omega-hydroxylated fatty acid derivative production when expressed in recombinant host cells. The disclosure further relates to microorganisms for expressing the omega-hydroxylase-related fusion polypeptides for the production of omega-hydroxylated fatty acid derivatives.
-
公开(公告)号:US20200299736A1
公开(公告)日:2020-09-24
申请号:US16664648
申请日:2019-10-25
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Jun Sun , Robin E. Osterhout , Priti Pharkya
IPC: C12P5/02 , C12N15/52 , C07C11/16 , C08F136/06
Abstract: The invention provides non-naturally occurring microbial organisms having a butadiene pathway. The invention additionally provides methods of using such organisms to produce butadiene.
-
公开(公告)号:US20200291436A1
公开(公告)日:2020-09-17
申请号:US16664526
申请日:2019-10-25
Applicant: Genomatica, Inc.
Inventor: Petronella Catharina Raemakers-Franken , Martin Schurmann , Axel Christoph Trefzer , Stefaan Marie Andre De Wildeman
IPC: C12P13/00 , C07C227/06 , C07D223/10 , C12P13/02 , C07D201/08
Abstract: The invention relates to a method for preparing 6-aminocaproic acid (hereinafter also referred to as ‘6-ACA’) using a biocatalyst. The invention further relates to a method for preparing ε-caprolactam (hereafter referred to as ‘caprolactam’) by cyclising such 6-ACA. The invention further relates to a host cell, a micro-organism, or a polynucleotide which may be used in the preparation of 6-ACA or caprolactam.
-
公开(公告)号:US20200095616A1
公开(公告)日:2020-03-26
申请号:US16428627
申请日:2019-05-31
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Stephen J. Van Dien , Mark J. Burk
Abstract: The invention provides a non-naturally occurring microorganism comprising one or more gene disruptions, the one or more gene disruptions occurring in genes encoding an enzyme obligatory to coupling 1,4-butanediol production to growth of the microorganism when the gene disruption reduces an activity of the enzyme, whereby theone or more gene disruptions confers stable growth-coupled production of 1,4-butanediol onto the non-naturally occurring microorganism. The microorganism can further comprise a gene encoding an enzyme in a 1,4-butanediol (BDO) biosynthetic pathway. The invention additionally relates to methods of using microorganisms to produce BDO.
-
公开(公告)号:US10563180B2
公开(公告)日:2020-02-18
申请号:US15027169
申请日:2014-10-03
Applicant: Genomatica Inc.
Inventor: Stefan Andrae , Michael Patrick Kuchinskas , Jingyi Li , Harish Nagarajan , Priti Pharkya
Abstract: Described herein are non-natural NAD+-dependent alcohol dehydrogenases (ADHs) capable of at least two fold greater conversion of methanol or ethanol to formaldehyde or acetaldehyde, respectively, as compared to its unmodified counterpart. Nucleic acids encoding the non-natural alcohol dehydrogenases, as well as expression constructs including the nucleic acids, and engineered cells comprising the nucleic acids or expression constructs are described. Also described are engineered cells expressing a non-natural NAD+-dependent alcohol dehydrogenase, optionally include one or more additional metabolic pathway transgene(s), methanol metabolic pathway genes, target product pathway genes, cell culture compositions including the cells, methods for promoting production of the target product or intermediate thereof from the cells, compositions including the target product or intermediate, and products made from the target product or intermediate.
-
177.
公开(公告)号:US10550411B2
公开(公告)日:2020-02-04
申请号:US15889788
申请日:2018-02-06
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Christophe H. Schilling , Anthony P. Burgard , John D. Trawick
Abstract: The invention provides a non-naturally occurring microbial organism having an acetyl-CoA pathway and the capability of utilizing syngas or syngas and methanol. In one embodiment, the invention provides a non-naturally occurring microorganism, comprising one or more exogenous proteins conferring to the microorganism a pathway to convert CO, CO2 and/or H2 to acetyl-coenzyme A (acetyl-CoA), methyl tetrahydrofolate (methyl-THF) or other desired products, wherein the microorganism lacks the ability to convert CO or CO2 and H2 to acetyl-CoA or methyl-THF in the absence of the one or more exogenous proteins. For example, the microbial organism can contain at least one exogenous nucleic acid encoding an enzyme or protein in an acetyl-CoA pathway. The microbial organism is capable of utilizing synthesis gases comprising CO, CO2 and/or H2, alone or in combination with methanol, to produce acetyl-CoA. The invention additionally provides a method for producing acetyl-CoA, for example, by culturing an acetyl-CoA producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an acetyl-CoA pathway enzyme or protein in a sufficient amount to produce acetyl-CoA, under conditions and for a sufficient period of time to produce acetyl-CoA.
-
公开(公告)号:US20190309329A1
公开(公告)日:2019-10-10
申请号:US16233018
申请日:2018-12-26
Applicant: Genomatica, Inc.
Inventor: Jun SUN , Anthony P. BURGARD , Priti PHARKYA
Abstract: The invention provides a non-naturally occurring microbial organism having a microbial organism having at least one exogenous gene insertion and/or one or more gene disruptions that confer production of primary alcohols. A method for producing long chain alcohols includes culturing these non-naturally occurring microbial organisms.
-
公开(公告)号:US20190264240A1
公开(公告)日:2019-08-29
申请号:US16216865
申请日:2018-12-11
Applicant: Genomatica, Inc.
Inventor: Robert Haselbeck , John D. Trawick , Wei Niu , Anthony P. Burgard
Abstract: The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO), 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway comprising at least one exogenous nucleic acid encoding a BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway enzyme expressed in a sufficient amount to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine.
-
公开(公告)号:US10351887B2
公开(公告)日:2019-07-16
申请号:US15634726
申请日:2017-06-27
Applicant: GENOMATICA, INC.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya , Mark J. Burk
IPC: C08G63/02 , C12P17/08 , C12N15/70 , C07D313/04 , C12N15/63 , C12P17/02 , C08G18/42 , C12N5/00 , C08G63/08 , C12N15/52
Abstract: The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.
-
-
-
-
-
-
-
-
-